LD-2 disclosure · 3rd Quarter - Report
ALVOGEN
Client
- Name
- ALVOGEN
- Description
- Pharmaceutical company developing and manufacturing generic, brand and biosimilar products
- Location
- New Jersey · United States of America
Registrant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals including Strategic National Stockpile appropriations and reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act; S.2624/HR 5894, the Fiscal Year 2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; the Fiscal Year 2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act
Lobbyistsms ANNA KATHERINE WEINSTEIN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)